Please login or register first to view this content.
Cardiovascular Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Study Examines Prevalence of BP-Elevating Med Use in Patients With Hypertension
Polypharmacy May Increase Risks for Kidney Failure, Cardiovascular Events
AHA: Oral Milvexian Promising for Prevention of VTE
AHA: Better Management of High Cholesterol Needed in Young Adults
Potassium Binder Fast Tracked for Reducing CV Outcomes in Chronic Hemodialysis
Drugs Prescribed Widely for Common Conditions Linked to Orthostatic Hypotension
ASN: PPI Use May Up Risk for AKI After Cardiac Surgery
BP Control Lower for Current Smokers, Especially Men
AHA: Sacubitril/Valsartan No More Beneficial for Chronic Advanced CHF
Does Calling a Colleague Physician an “Idiot” Constitute Defamation?
Empagliflozin Gets Priority Review for Heart Failure Independent of LVEF
Yutrepia Gets Tentative Approval for Pulmonary Arterial Hypertension
AHA: E-Cigarette Use Linked to Risk for Stroke at a Younger Age
LDL-C Reduction Observed With Inclisiran Regardless of BMI
AHA: Early Epinephrine Administration in OHCA Beneficial
Empagliflozin: Cardio-Renal Benefits in HF, LVEF Above 40% Regardless of CKD Status
Guideline Addresses Diagnosis, Evaluation of Chest Pain in Adults
AHA Issues Dietary Guidance to Aid Cardiometabolic Health
